首页> 外文OA文献 >A mutation in the ATP-binding site of the Kir6.2 subunit of the KATP channel alters coupling with the SUR2A subunit.
【2h】

A mutation in the ATP-binding site of the Kir6.2 subunit of the KATP channel alters coupling with the SUR2A subunit.

机译:KATP通道的Kir6.2亚基的ATP结合位点中的突变会改变与SUR2A亚基的偶联。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Mutations in the pore-forming subunit of the ATP-sensitive K(+) (K(ATP)) channel Kir6.2 cause neonatal diabetes. Understanding the molecular mechanism of action of these mutations has provided valuable insight into the relationship between the structure and function of the K(ATP) channel. When Kir6.2 containing a mutation (F333I) in the putative ATP-binding site is coexpressed with the cardiac type of regulatory K(ATP) channel subunit, SUR2A, the channel sensitivity to ATP inhibition is reduced and the intrinsic open probability (P(o)) is increased. However, the extent of macroscopic current activation by MgADP was unaffected. Here we examine rundown and MgADP activation of wild-type and Kir6.2-F333I/SUR2A channels using single-channel recording, noise analysis and spectral analysis. We also compare the effect of mutating the adjacent residue, G334, on rundown and MgADP activation. All three approaches indicated that rundown of Kir6.2-F333I/SUR2A channels is due to a reduction in the number of active channels in the patch and that MgADP reactivation involves recruitment of inactive channels. In contrast, rundown and MgADP reactivation of wild-type and Kir6.2-G334D/SUR2A channels, and of Kir6.2-F333I/SUR1 channels, involve a gradual change in P(o). Our results suggest that F333 in Kir6.2 interacts functionally with SUR2A to modulate channel rundown and MgADP activation. This interaction is fairly specific as it is not disturbed when the adjacent residue (G334) is mutated. It is also not a consequence of the enhanced P(o) of Kir6.2-F333I/SUR2A channels, as it is not found for other mutant channels with high P(o) (Kir6.2-I296L/SUR2A).
机译:ATP敏感性K(+)(K(ATP))通道Kir6.2的孔形成亚基中的突变引起新生儿糖尿病。了解这些突变的分子作用机理已经为了解K(ATP)通道的结构与功能之间的关系提供了宝贵的见识。当在假定的ATP结合位点中含有突变(F333I)的Kir6.2与心脏类型的调节性K(ATP)通道亚基SUR2A共表达时,通道对ATP抑制的敏感性降低,内在打开概率(P( o))增加。但是,MgADP激活宏观电流的程度不受影响。在这里,我们使用单通道记录,噪声分析和频谱分析来检查野生型和Kir6.2-F333I / SUR2A通道的降解和MgADP激活。我们还比较了突变相邻残基G334对减少和MgADP激活的影响。所有这三种方法均表明Kir6.2-F333I / SUR2A通道的减少是由于补丁中有效通道的数量减少,并且MgADP重新激活涉及募集了无效通道。相反,野生型和Kir6.2-G334D / SUR2A通道以及Kir6.2-F333I / SUR1通道的降解和MgADP激活涉及P(o)的逐渐变化。我们的结果表明,Kir6.2中的F333与SUR2A在功能上相互作用,以调节通道减少和MgADP激活。这种相互作用是相当特异性的,因为当相邻残基(G334)发生突变时不会受到干扰。这也不是Kir6.2-F333I / SUR2A通道增强的P(o)的结果,因为对于其他具有高P(o)(Kir6.2-I296L / SUR2A)的突变型通道则没有发现。

著录项

  • 作者

    Tammaro, P; Ashcroft, FM;

  • 作者单位
  • 年度 2007
  • 总页数
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号